DRAMAMINE CHEWABLE OTC
Generic Name and Formulations:
Dimenhydrinate 50mg; scored chewable tabs; contains phenylalanine, tartrazine.
McNeil Consumer Healthcare
Indications for DRAMAMINE CHEWABLE:
Motion sickness prophylaxis.
50–100mg every 4–6 hours, starting ½–1 hour before travel; max 400mg/day.
<2 years: not recommended. 2–6 years: 12.5–25mg; max 75mg/day. 6–11 yrs: 25–50mg; max 150mg/day. Both: starting ½–1 hour before travel; may repeat every 6–8 hours.
Asthma or chronic respiratory disease. Glaucoma. Arrhythmias. GI or urinary obstruction. Phenylketonuria (chewable tabs). Pregnancy (Cat.B). Nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants. May potentiate ototoxicity of antibiotics (esp. aminoglycosides).
Drowsiness, sedation, anticholinergic effects, paradoxical excitement in children.
Tabs—12, 36, 100
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age